Premium
Relative and Absolute Bioavailability of Prednisone and Prednisolone After Separate Oral and Intravenous Doses
Author(s) -
Ferry J. J.,
Horvath A. M.,
Bekersky I.,
Heath E. C.,
Ryan C. F.,
Colburn W. A.
Publication year - 1988
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1988.tb03105.x
Subject(s) - bioavailability , prednisolone , prednisone , medicine , pharmacology , pharmacokinetics , oral dose
A randomized, four‐way cross‐over study was conducted in eight healthy male volunteers to determine the relative and absolute bioavailability of prednisone (PN) and prednisolone (PL). PN and PL were administered as single, oral 10‐mg tablet doses and as 10‐mg zero‐order 0.5‐hour intravenous infusions. Comparable mean PN and PL maximum plasma concentrations (C max ), times for C max , areas under the plasma concentration‐time curves (AUC), and apparent elimination rate constants between tablet treatments demonstrated that PN and PL tablets were bioequivalent. Absolute bioavailability (F) determinations based on plasma PL concentrations were independent of which IV treatment was used as reference and indicated complete systemic availability of PL from both PN and PL tablets. However, F based on plasma PN data was contradictory. Using IV PN as reference, approximately 70% systemic availability was observed from both tablets, whereas using IV PL as reference, systemic availability was greater than unity. PN and PL are model compounds that exemplify the difficulties involved in accurately determining the relative and absolute bioavailability of substances that undergo reversible metabolism.